Results 231 to 240 of about 29,386 (262)

Insight into the screening of potential beta-lactamase inhibitors as anti-bacterial chemical agents through pharmacoinformatics study

Journal of Biomolecular Structure and Dynamics, 2021
Pratap Parida, Shovonlal Bhowmick, Achintya Saha   +2 more
exaly  

Evolution of beta-lactamase inhibitors.

Pharmacotherapy, 1991
After the introduction of penicillin G into therapeutics, bacteria became increasingly resistant to this penicillin and subsequent beta-lactam antibiotics. The major cause of this resistance is beta-lactamase, an enzyme produced by the bacterium, that destroys the antibiotic before it reaches its target within the bacterial cell.
openaire   +1 more source

Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections

Médecine Et Maladies Infectieuses, 2020
J P Bru, S Alfandari, Alexandre Bleibtreu   +2 more
exaly  

Beta-lactam resistance in Campylobacter coli and Campylobacter jejuni chicken isolates and the association between blaOXA-61 gene expression and the action of β-lactamase inhibitors

Veterinary Microbiology, 2020
Patrizia Casagrande Proietti, Gabriella Guelfi, Silvio De Luca   +2 more
exaly  

Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis

International Journal of Antimicrobial Agents, 2018
Maroun M Sfeir, Gülce Askin, Paul Christos   +2 more
exaly  

Implications of beta-lactamase-inhibitor combinations.

The Journal of reproductive medicine, 1988
Ticarcillin disodium/clavulanate potassium and other beta-lactamase inhibitor/penicillin combinations have been recognized recently as broad-spectrum drugs that have a major role in chemotherapy for serious surgical sepsis. Their spectrum of activity allows the economical substitution of ticarcillin disodium/clavulanate potassium for anaerobe-active ...
openaire   +1 more source

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update

Critical Reviews in Microbiology, 2009
Haris M Khan, P M Hawkey
exaly  

Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii

Bioorganic and Medicinal Chemistry Letters, 2011
Milton L Hammond
exaly  

[Beta-lactamase inhibitors].

Nihon rinsho. Japanese journal of clinical medicine, 1992
H, Nishiya, O, Kunii
openaire   +1 more source

Beta-lactamase inhibitors

2016
openaire   +1 more source